These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11373776)

  • 21. Switching from protease inhibitors to the non-nuke efavirenz.
    TreatmentUpdate; 2001; 12(12):3. PubMed ID: 11570089
    [No Abstract]   [Full Text] [Related]  

  • 22. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051
    [No Abstract]   [Full Text] [Related]  

  • 23. [CROI--presentation of new study results. In a comparison of NNRTI nevirapine is equally effective].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373068
    [No Abstract]   [Full Text] [Related]  

  • 24. A new HAART on the horizon says the proof is in the potency.
    AIDS Alert; 1999 Apr; 14(4):37-9. PubMed ID: 11366218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four-drug regimens may be better.
    AIDS Patient Care STDS; 2000 Dec; 14(12):671. PubMed ID: 11119435
    [No Abstract]   [Full Text] [Related]  

  • 26. Female sex but not ethnicity is a strong predictor of non-nucleoside reverse transcriptase inhibitor-induced rash.
    Mazhude C; Jones S; Murad S; Taylor C; Easterbrook P
    AIDS; 2002 Jul; 16(11):1566-8. PubMed ID: 12131201
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of NNRTIs in antiretroviral-experienced patients.
    Maggiolo F
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():10-7. PubMed ID: 11589823
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of NNRTIs in antiretroviral combination therapy: an introduction.
    Nelson M
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():1-2. PubMed ID: 11589821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.
    Delaugerre C; Rohban R; Simon A; Mouroux M; Tricot C; Agher R; Huraux JM; Katlama C; Calvez V
    J Med Virol; 2001 Nov; 65(3):445-8. PubMed ID: 11596076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manic syndrome associated with efavirenz overdose.
    Blanch J; Corbella B; García F; Parellada E; Gatell JM
    Clin Infect Dis; 2001 Jul; 33(2):270-1. PubMed ID: 11418896
    [No Abstract]   [Full Text] [Related]  

  • 31. Switch study of nevirapine.
    AIDS Patient Care STDS; 2000 Dec; 14(12):672. PubMed ID: 11187109
    [No Abstract]   [Full Text] [Related]  

  • 32. DMP 266 trials recruiting, many cities -- protease inhibitor naive.
    James JS
    AIDS Treat News; 1997 Sep; (No 278):5-6. PubMed ID: 11364623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs of tomorrow.
    Posit Aware; 1998; 9(3):27-31. PubMed ID: 11365484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Valuable combination partner. Great benefit for therapy naive patients].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():82-4. PubMed ID: 15373061
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():42-3. PubMed ID: 16385872
    [No Abstract]   [Full Text] [Related]  

  • 37. Other issues: penetration into sanctuary sites, immune reconstitution and NNRTI sequencing.
    Stellbrink HJ
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():25-32. PubMed ID: 11589825
    [No Abstract]   [Full Text] [Related]  

  • 38. Top stories of 2004. Nevirapine and efavirenz: similar efficacy, different toxicities, and better separately than combined.
    Friedland G
    AIDS Clin Care; 2005 Jan; 17(1):5. PubMed ID: 15717369
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.
    Ritchie MD; Haas DW; Motsinger AA; Donahue JP; Erdem H; Raffanti S; Rebeiro P; George AL; Kim RB; Haines JL; Sterling TR
    Clin Infect Dis; 2006 Sep; 43(6):779-82. PubMed ID: 16912956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.